SIM
GILD icon

Synergy Investment Management’s Gilead Sciences GILD Stock Holding History

Synergy Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.1K Buy
583
+54
+10% +$7.12K 0.02% 322
2026
Q1 		$73.7K Buy
+529
New +$74.1K 0.02% 236
2025
Q2 		– Sell
-428
Closed -$47.9K – 277
2025
Q1 		$47.9K Hold
428
– – 0.02% 240
2024
Q4 		$39.5K Buy
+428
New +$38.5K 0.02% 260

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Synergy Investment Management's GILD Position: Q2 2026 in Review

Synergy Investment Management increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $7.12K and bringing the position to 583 shares worth $74.1K. The position accounts for 0.02% of the portfolio, ranked #322.

Synergy Investment Management first reported a position in GILD in Q4 2024 and has held it in 4 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Synergy Investment Management held 583 shares of Gilead Sciences worth $74.1K as of Q2 2026.
  • Synergy Investment Management bought 54 Gilead Sciences shares in Q2 2026, an estimated $7.12K.
  • Gilead Sciences made up 0.02% of Synergy Investment Management's portfolio in Q2 2026, its #322 holding.
  • Synergy Investment Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 4 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Synergy Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.